CL2012000429A1 - Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias. - Google Patents
Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias.Info
- Publication number
- CL2012000429A1 CL2012000429A1 CL2012000429A CL2012000429A CL2012000429A1 CL 2012000429 A1 CL2012000429 A1 CL 2012000429A1 CL 2012000429 A CL2012000429 A CL 2012000429A CL 2012000429 A CL2012000429 A CL 2012000429A CL 2012000429 A1 CL2012000429 A1 CL 2012000429A1
- Authority
- CL
- Chile
- Prior art keywords
- allergies
- elaboration
- symptoms
- serves
- reduce
- Prior art date
Links
- 241001608472 Bifidobacterium longum Species 0.000 title abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 2
- 230000007815 allergy Effects 0.000 title abstract 2
- 229940009291 bifidobacterium longum Drugs 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Uso de cepas de bifidobacterium longum para la elaboración de una completa composición que sirve para reducir los síntomas de alergias.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09168049 | 2009-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012000429A1 true CL2012000429A1 (es) | 2012-09-28 |
Family
ID=41491661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012000429A CL2012000429A1 (es) | 2009-08-18 | 2012-02-17 | Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias. |
Country Status (17)
Country | Link |
---|---|
US (1) | US9439449B2 (es) |
EP (1) | EP2467032B1 (es) |
CN (1) | CN102905557A (es) |
AU (1) | AU2010285128B2 (es) |
BR (1) | BR112012003633A2 (es) |
CA (1) | CA2770062A1 (es) |
CL (1) | CL2012000429A1 (es) |
ES (1) | ES2664724T3 (es) |
MX (1) | MX341971B (es) |
MY (1) | MY163002A (es) |
PT (1) | PT2467032T (es) |
RU (1) | RU2539514C2 (es) |
SG (1) | SG178167A1 (es) |
TR (1) | TR201807156T4 (es) |
TW (1) | TW201124089A (es) |
WO (1) | WO2011020748A1 (es) |
ZA (1) | ZA201201991B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2449890A1 (en) * | 2010-11-05 | 2012-05-09 | Nestec S.A. | Powdered cereal compositions comprising non-replicating probiotic microorganisms |
EP3366143A1 (en) | 2011-06-20 | 2018-08-29 | H.J. Heinz Company Brands LLC | Probiotic compositions and methods |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
EP2617296A1 (en) | 2012-01-19 | 2013-07-24 | Nestec S.A. | A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
CN103820357A (zh) * | 2013-12-30 | 2014-05-28 | 上海交大昂立股份有限公司 | 一株长双歧杆菌及其防治食物过敏的功能 |
SI3193901T1 (en) | 2014-12-23 | 2018-06-29 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
NO3065748T3 (es) | 2014-12-23 | 2018-04-21 | ||
SG10201912324XA (en) | 2015-06-15 | 2020-02-27 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
ME03563B (me) | 2015-06-15 | 2020-07-20 | 4D Pharma Res Ltd | Kompozicije koje sadrže bakterijske sojeve |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
HUE044617T2 (hu) | 2015-06-15 | 2019-11-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
AU2016315266B2 (en) * | 2015-08-31 | 2022-12-22 | Société des Produits Nestlé S.A. | Methods and compositions using Bifidobacterium longum to treat or prevent depressive symptoms |
MD3209310T2 (ro) | 2015-11-20 | 2018-06-30 | 4D Pharma Res Ltd | Compoziții care conțin tulpini bacteriene |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
CN114712405A (zh) | 2016-03-04 | 2022-07-08 | 4D制药有限公司 | 包含细菌菌株的组合物 |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
EP3630137B1 (en) | 2017-05-22 | 2023-05-17 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
SI3638271T1 (sl) | 2017-06-14 | 2021-01-29 | 4D Pharma Research Limited | Sestavki, ki vsebujejo bakterijske seve |
PL3600364T3 (pl) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozycje zawierające szczep bakteryjny z rodzaju megasphaera i ich zastosowania |
CN111479927A (zh) * | 2017-12-29 | 2020-07-31 | 雀巢产品有限公司 | 丝氨酸蛋白酶抑制剂生产 |
CN109212129A (zh) * | 2018-06-30 | 2019-01-15 | 湖北海纳天鹰科技发展有限公司 | 一种规避空气中过敏原的目的地选择方法和装置 |
WO2020070087A1 (en) * | 2018-10-02 | 2020-04-09 | Société des Produits Nestlé S.A. | Probiotic combination for treatment of inflammatory-related gastrointestinal disorders |
CN113660941A (zh) * | 2018-12-21 | 2021-11-16 | 雀巢产品有限公司 | 用于治疗变态反应性疾病的益生菌组合 |
CN112159784A (zh) * | 2020-10-29 | 2021-01-01 | 佛山市朗芯生物科技有限公司 | 长双歧杆菌nx-4及其在制备治疗和/或预防过敏性疾病药物中的应用 |
CH718355A2 (fr) * | 2021-02-16 | 2022-08-31 | Nestle Sa | Composition et kit pour soulager les symptômes de l'allergie respiratoire. |
AU2022307441A1 (en) * | 2021-07-09 | 2024-01-25 | Société des Produits Nestlé S.A. | Uses of bifidobacterium longum transitional microorganism |
TW202345883A (zh) * | 2022-02-25 | 2023-12-01 | 瑞士商雀巢製品股份有限公司 | 長雙歧桿菌過渡微生物之用途 |
WO2024008851A1 (en) * | 2022-07-08 | 2024-01-11 | Société des Produits Nestlé S.A. | Uses of bifidobacterium longum transitional microorganism |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
JPH10309178A (ja) | 1997-05-09 | 1998-11-24 | Wakamoto Pharmaceut Co Ltd | ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品 |
EP1227152A1 (en) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bacterial strain and genome of bifidobacterium |
EP2033529B1 (en) | 2003-10-24 | 2019-12-11 | N.V. Nutricia | Synbiotic composition for infants |
JP2006028050A (ja) | 2004-07-14 | 2006-02-02 | Combi Corp | 皮膚アレルギー抑制組成物 |
JP5273695B2 (ja) | 2005-03-03 | 2013-08-28 | 株式会社明治 | ビフィズス菌を有効成分とするアレルギー予防および/または治療剤 |
TW200700074A (en) | 2005-03-04 | 2007-01-01 | Calpis Co Ltd | Inducer of t cell apoptosis |
WO2006097949A1 (en) | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
ES2381211T3 (es) * | 2006-02-15 | 2012-05-24 | Nestec S.A. | Uso del Bifidobacterium longum para prevenir y tratar inflamaciones |
WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
JP2009060800A (ja) | 2007-09-04 | 2009-03-26 | Tsujido Kagaku Kk | 食品組成物 |
CN101969966B (zh) | 2007-12-07 | 2013-05-08 | 努特里希亚公司 | 用于尘螨变态反应的双歧杆菌 |
-
2010
- 2010-08-11 MX MX2012001902A patent/MX341971B/es active IP Right Grant
- 2010-08-11 ES ES10741961.6T patent/ES2664724T3/es active Active
- 2010-08-11 WO PCT/EP2010/061666 patent/WO2011020748A1/en active Application Filing
- 2010-08-11 MY MYPI2012000418A patent/MY163002A/en unknown
- 2010-08-11 PT PT107419616T patent/PT2467032T/pt unknown
- 2010-08-11 CN CN2010800368742A patent/CN102905557A/zh active Pending
- 2010-08-11 CA CA2770062A patent/CA2770062A1/en not_active Abandoned
- 2010-08-11 AU AU2010285128A patent/AU2010285128B2/en active Active
- 2010-08-11 RU RU2012110170/13A patent/RU2539514C2/ru not_active IP Right Cessation
- 2010-08-11 BR BRBR112012003633-5A patent/BR112012003633A2/pt not_active Application Discontinuation
- 2010-08-11 EP EP10741961.6A patent/EP2467032B1/en active Active
- 2010-08-11 TR TR2018/07156T patent/TR201807156T4/tr unknown
- 2010-08-11 US US13/391,172 patent/US9439449B2/en active Active
- 2010-08-11 SG SG2012006490A patent/SG178167A1/en unknown
- 2010-08-18 TW TW099127614A patent/TW201124089A/zh unknown
-
2012
- 2012-02-17 CL CL2012000429A patent/CL2012000429A1/es unknown
- 2012-03-16 ZA ZA2012/01991A patent/ZA201201991B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20120164109A1 (en) | 2012-06-28 |
TW201124089A (en) | 2011-07-16 |
US9439449B2 (en) | 2016-09-13 |
TR201807156T4 (tr) | 2018-06-21 |
WO2011020748A1 (en) | 2011-02-24 |
PT2467032T (pt) | 2018-04-04 |
CN102905557A (zh) | 2013-01-30 |
MY163002A (en) | 2017-07-31 |
BR112012003633A2 (pt) | 2015-09-01 |
RU2539514C2 (ru) | 2015-01-20 |
EP2467032A1 (en) | 2012-06-27 |
SG178167A1 (en) | 2012-03-29 |
EP2467032B1 (en) | 2018-02-21 |
AU2010285128A1 (en) | 2012-03-08 |
MX341971B (es) | 2016-09-08 |
RU2012110170A (ru) | 2013-09-27 |
AU2010285128B2 (en) | 2015-05-14 |
CA2770062A1 (en) | 2011-02-24 |
ES2664724T3 (es) | 2018-04-23 |
ZA201201991B (en) | 2014-08-27 |
MX2012001902A (es) | 2012-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2012000429A1 (es) | Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias. | |
CL2012000417A1 (es) | Uso de cepas de lactococcus que sirve para reducir los sintomas de alergias. | |
ECSP11011557A (es) | Mimético de smac | |
CL2011000214A1 (es) | Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona. | |
ECSP11011436A (es) | ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS Y MÉTODOS DE USO | |
CR20120011A (es) | Inhibidores de bace | |
ECSP14013169A (es) | Tableta a prueba de alteración que proporciona liberación inmediata del fármaco | |
CL2011000098A1 (es) | Uso de una betadefensina de mamifero para tratar enfermedad inflamatoria. | |
BR112015003282A2 (pt) | composições de cimento de geopolímero e métodos de uso | |
CR11232A (es) | Compuestos de tiazolopirina modulares de sirtuina | |
CR20140318A (es) | Composiciones intranasales de dexmedetomidina y métodos de uso de ellas | |
CL2012000921A1 (es) | Compuestos derivados de espiropiperidina-metilbenciloxifenil, activadores del receptor rpg-40; composicion farmaceutica que los comprende; y uso del compuesto para tratar diabetes. | |
CU20130058A7 (es) | Polipéptidos del factor ix modificados y usos de los mismos | |
CL2008001835A1 (es) | Uso de compuestos derivados de guaninas policiclicas para tratar la inflamacion; compuestos derivados de guanina; y compocicion farmaceutica que los comprende. | |
UY33124A (es) | Agentes y epítopos enlazados a wise | |
CL2013000734A1 (es) | Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para bajar la presion intraocular; kit farmaceutico. | |
SV2009003429A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
ECSP099561A (es) | Formulación de nevirapina de liberación prolongada | |
CL2011002258A1 (es) | Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih. | |
HN2010001537A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
ES2415029R1 (es) | Composición farmacéutica y método para inhibir la producción o amplificar la eliminación de la proteína P24. | |
DOP2010000361A (es) | Dronedarona para la prevencion de la cardioversion | |
CR20120094A (es) | Un antibiótico novedoso que comprende un anticuerpo mimético, métodos de preparación y usos del mismo | |
SV2010003773A (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
UY32112A (es) | Compuestos que se unen a las placas amiloides para obtener imágenes de las mismas y su uso |